- Filed
- Oct 21, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Oct 16, 2024 | 798.51M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 690.75M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 431.42M sh |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2024 | −$988.73K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$1.14M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $1.75M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $1.75M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$5.3M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | −$4.24M |
| Current Liabilities restated | Q1 2024 · Mar 31, 2024 | $12.63M |
| Current Liabilities restated | Q1 2024 · Dec 31, 2023 | $11.28M |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $14.38M |
| Total Liabilities restated | Q1 2024 · Dec 31, 2023 | $13.03M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $1.05M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $852.55K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $10.87M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $10.59M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense restated | Q1 2024 · Mar 31, 2024 | $338.96K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $249.95K |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $28.52K |
| Net Income restated | Q1 2024 · Mar 31, 2024 | −$2.2M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$2.7M |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$1.32M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$1.46M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $52.68K |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $2.99K |
| Revenue | Q1 2024 · Mar 31, 2024 | $49.69K |